Week 568 Review - Another bad week as gold slips

Another bad week. It got worse every day and ended up widening the deficit between cost and value by £1,118 to £156,106 and the deficit between injection and value grew to £63,828. Total portfolio value dropped to £121,560.

Biggest loser was IES:Invinity Energy which dropped 22% after a recent spike upwards. There was no news so presumably just profit taking.

GGP:Greatland Resources was the worst of the gold miners, dropping 10% as the price of gold continued to slip.

HPOW:H-Power drifted down another 10% on no news.

CORE:Solidcore Resources fell 8%.

AMP:Ampeak Energy dropped 7% as all the shares related to renewable energy had a bad week.

MSI:MS International  and PAGE:Pagegroup both dropped 6% for no particular reason

AMRQ:Amaroq, ATYM:Atalya Mining, THX:Thor Explorations and W7L:Warpaint London all dropped 5%.

MGNS:Morgan Sindall Group climbed 5% and went 3% into profit.

SBRE:Sabre Insurance climbed 6% and is now 11% up.

GAW:Games Workshop went up 8% to go 79% up.

TAM:Tatton Asset Management also climbed 8% and is now 28% up.

OPTI:Optibiotix went up 9% for no obvious reason but is still at a massive loss.

SBTX:SkinBioTherapeutics also went up 9% and is now worth twice as much as OPTI.

Share of the Week is III:3i Group which recovered 15% of recent losses after a positive update from Action, but my holding is still 17% down.

Here's the ISA and shares portfolio after week 48 of year 11.

			Weekly Change
Cash	£105.89		+£0.08
Portfolio cost	£116,490.29		+£0
Portfolio sell value (bid price-commission)	£31,996.76	(-72.5%)	-£113.09
Potential profits	£330.10		-£114.24
Yr 11 Dividends	£86.83		+£0
Yr 11 Interest	£1.61		+£0.04
Yr 11 Profit from sales	£873.14		+£0
Yr 11 proj avg monthly profit	£79.05	(1.1%)	-£1.68
Total Dividends	£12,574.90		+£0
Total Interest	£10.18		+£0.04
Total Profit from sales	£18,433.41		+£0
Average monthly cash profit	£231.67	(3.2%)	-£0.44
(Sold stocks profit + Dividends - Fees / Months)

Nearly all losses were in potential profits thanks to the drop in IES:Invinity Energy.

Still flat

Still hugging the trend line

Still rubbish.

The SIPP looks like this after week 552 overall and week 32 of year 11.

			Weekly Change
Cash	£856.47		+£2.18
Portfolio cost	£160,213.80		+£0
Portfolio sell value (bid price - commission)	£88,601.26	(-44.7%)	-£1,005.29
Potential profits	£9,959.82		-£770.89
Yr 11 Dividends	£1.516.17		+£39.10
Yr 11 Interest	£12.50		+£0.24
Yr 11 Profit from sales	£9,397.72		+£0
Yr 11 proj avg monthly profit	£1,461.80	(17.7%)	-£41.65
Total Dividends	£19,736.37		+£39.10
Total Interest	£33.20		+£0.24
Total Profit from sales	£34,064.23		+£0
Average monthly cash profit	£408.85	(5.0%)	-£0.43

A big £1,005 drop in value, £770 if which was lost potential profit as gold and many magic formula shares were hit. I got £13 dividend from FDM:FDM Group and £25 from IHP:Integrafin. Not much else happened.

Sliding

Still below the trend line

Well below the trend line now.

Nothing more to say as I was a week late writing this.

Week 567 Review - Just in the black, but most gains lost at the end of the week.

It was a positive week, but didn't feel it after being up by over £4,000 mid-week and seeing most of that vanish as the week ended, with the deficit between cost and value just £591 less and the deficit reduced to £154,987. The deficit between injection and value reduced to £62,712 and total portfolio value increased to £122,676.

Worst performer was RAT:Rathbones, dropping 18% after announcing a series of measures following an FCA assessment of their operation. It will hit profits, but not by 18% so I'm hoping they will recover.

CKN:Clarkson  dropped 9%, presumably because things are easing up in the Middle East and much of the recent rise has been off the back of the complexities with shipping out there.

PAGE:Pagegroup continue their decline, with a 9% drop for no obvious reason. My holding is now 78% down, making this one of my worst performing magic formula shares.

BTG:BTG Consulting fell 7%, possibly due to people thinking the ceasefire in the Middle East will improve the economy to the detriment of BTG. I don't think that's the case, so may use this as an opportunity to buy more when my next pension transfer comes through.

OPTI:Optibiotix fell another 5% and there's no sign of anything changing.

RIO:Rio Tinto was the worst of the miners, dropping 5% when the rest were either flat or reasonably up.

EDV:Endeavour Mining went up 5%, and ATYM:Atalya Mining 6% but mid-week they were up by twice that.

AMP:Ampeak Energy climbed 8% for no obvious reason, but my holding is still 64% down.

GGP:Greatland Resources was the best of the miners, climbing 10% to go 94% up.

IES:Invinity Energy zoomed up 22% after another contract was announced.

SBTX:SkinBioTherapeutics dropped badly after being removed from suspension last week, but this week climbed 38% presumably on hopes that one day Croda might sell something.

I'm awarding Share of the Week to TAM:Tatton Asset Management. They climbed 18% which is amazing for a magic formula share. This was on the back of final results significantly exceeding expectations. I'm hopeful this has much further to run.

Here's the ISA and shares portfolio after week 47 of year 11.

			Weekly Change
Cash	£105.81		-£3.92
Portfolio cost	£116,490.29		+£0
Portfolio sell value (bid price-commission)	£32,109.85	(-72.4%)	+£578.37
Potential profits	£444.34		+£92.82
Yr 11 Dividends	£86.83		+£0
Yr 11 Interest	£1.57		+£0
Yr 11 Profit from sales	£873.14		+£0
Yr 11 proj avg monthly profit	£80.73	(1.1%)	-£2.13
Total Dividends	£12,574.90		+£0
Total Interest	£10.14		+£0
Total Profit from sales	£18,433.41		+£0
Average monthly cash profit	£232.08	(3.2%)	-£0.44
(Sold stocks profit + Dividends - Fees / Months)

Monthly fees slightly reduced cash, portfolio value up by £578 thanks to the big increases in IES:Invinity Energy and SBTX:SkinBioTherapeutics, and the £92 gain in potential profits was mainly down to IES.

Still pretty flat.

Back up almost on the trend line

The SIPP looks like this after week 551 overall and week 31 of year 11.

			Weekly Change
Cash	£854.29		+£40.14
Portfolio cost	£160,213.80		+£0
Portfolio sell value (bid price - commission)	£89,606.55	(-44.1%)	+£7.68
Potential profits	£10,730.71		+£278.66
Yr 11 Dividends	£1.477.07		+£44.41
Yr 11 Interest	£12.26		+£0
Yr 11 Profit from sales	£9,397.72		+£0
Yr 11 proj avg monthly profit	£1,503.45	(18.2%)	-£44.32
Total Dividends	£19,697.27		+£44.41
Total Interest	£32.96		+£0
Total Profit from sales	£34,064.23		+£0
Average monthly cash profit	£409.28	(5.0%)	-£0.43

Cash was up thanks to a £6 dividend from PAGE:Pagegroup and £37 from YU.:Yu Group, minus monthly fees. Portfolio value was just about as flat as it could be, but potential profits increased £278 mostly thanks to TAM:Tatton Asset Management.

I had a feeling I was never going to close the gap to the injection line, and that does seem to be the case.

Still well below the trend line.

Leaving the trend line behind here too.

I'm not terribly optimistic about things getting better in the Middle East, given Israel are acting as if there's no ceasefire. Markets will continue to fluctuate wildly so I may as well just accept the fact there's not likely to be any recovery in my portfolio value for the rest of the summer at least.

Week 566 Review - Bad week for the ISA and flat for the SIPP

This week could have been a lot worse. I was down by £4.5k by Thursday evening, but a big rally on Friday reduced my deficit to £1,511. It means the deficit between cost and value widens to £155,573 and the deficit between injection and value increases to £63,334. Total portfolio value drops to £122,054.

Worst performer was IES:Invinity Energy, dropping 21% as people took profits following the recent surge. I guess it was bound to happen.

SBTX:SkinBioTherapeutics shares began trading again after they completed the fraud investigation. They ended up 16% down, but at one point in the week were 37% down, so this isn't bad.

HPOW:H-Power suffered a similar fate to IES, dropping 12% after recent strong gains.

THX:Thor Explorations was the worst hit of my gold miners, dropping 6%. Most of them were down this week, but not by that much.

Share of the Week is shared between GAW:Games Workshop and SBRE:Sabre Insurance, as both climbed 5% and were my only big risers this week.

Here's the ISA and shares portfolio after week 46 of year 11.

			Weekly Change
Cash	£109.73		+£0
Portfolio cost	£116,490.29		+£0
Portfolio sell value (bid price-commission)	£31,531.48	(-72.9%)	-£1,259.89
Potential profits	£351.52		-£104.52
Yr 11 Dividends	£86.83		+£0
Yr 11 Interest	£1.57		+£0
Yr 11 Profit from sales	£873.14		+£0
Yr 11 proj avg monthly profit	£82.86	(1.1%)	-£1.84
Total Dividends	£12,574.90		+£0
Total Interest	£10.14		+£0
Total Profit from sales	£18,433.41		+£0
Average monthly cash profit	£232.52	(3.2%)	-£0.41
(Sold stocks profit + Dividends - Fees / Months)

Most of my losses were in my ISA this week, with big drops for HPOW:H-Power, IES:Invinity Energy and SBTX:SkinBioTherapeutics, with the drop in IES reducing potential profits by £104.

The rise is looking more like a blip along a steady decline.

Back below the trend line

The SIPP looks like this after week 550 overall and week 30 of year 11.

			Weekly Change
Cash	£814.15		-£467.92
Portfolio cost	£160,213.80		+£493.00
Portfolio sell value (bid price - commission)	£89,598.87	(-44.1%)	-£251.52
Potential profits	£10,452.05		+£234.41
Yr 11 Dividends	£1.432.66		+£25.08
Yr 11 Interest	£12.26		+£0
Yr 11 Profit from sales	£9,397.72		+£0
Yr 11 proj avg monthly profit	£1,547.77	(18.8%)	-£49.62
Total Dividends	£19,652.86		+£25.08
Total Interest	£32.96		+£0
Total Profit from sales	£34,064.23		+£0
Average monthly cash profit	£409.71	(5.0%)	-£0.55

It was monthly investment time. I bought 106 shares in ESTC:European Smaller Companies Trust at 232.9611p costing £248.17 and 35 shares in BPM:BP Marsh & Partners at 699.5p costing £244.83. I've bought as many ESTC as I want now, but will continue with BPM for a few more months.

Portfolio value only dropped £251 and potential profits actually went up £234 and I got a £25 dividend from GCP:GCP Infrastructure Investments.

Still tantalisingly close to the injection line

Still below the trend line.

Hoping I can stay above £400 until August when I clear out some of my magic formula shares, hopefully for lots of profit.

There was an encouraging presentation from JLP:Jubilee Metals about their Molefe mine this week. It got me all excited in JLP again, but I'm not making the mistake of buying more shares. Every time I do that, the share price drops even further. I am optimistic it will turn around some time this summer when they can show production is increasing. That will be a game changer for my performance in both accounts. It's just taking a very, very long time. I need to keep reminding myself that I've been in this position with JLP before, but have made £1,700 profit in my SIPP and a massive £13,183 in my ISA, so this has been one of my best ever shares. There is hope!

Week 565 Review - SIPP hammered, ISA flat.

A dreadful week for the SIPP, with huge drops especially in miners. The ISA actually ended up in the black. The overall effect was a widening of the deficit between cost and value by £3,745 to £154,062 and a widening of the deficit between injection and value to £61,848. Total portfolio value fell to £123,540.

Worst performer by a long way was PAF:Pan African Resources, dropping 23% after an operational update that wasn't really bad. I guess given all gold miners were hammered this week, it's not a surprise. I took advantage of the drop to buy some more.

EDV:Endeavour Mining dropped 13% and is now only 4% in profit, which is amazing given the price of gold.

PRU:Prudential fell 12% and are now at a loss by 3%. It sounds like investors were spooked by performance in China.

THX:Thor Explorations also dropped 12% following the trend amongst miners.

ATYM:Atalya Mining fell 10% and my ISA holding is no longer in profit.

FRES:Fresnillo and GGP:Greatland Resources both fell 9% which was pretty good compared to the rest.

FDM:FDM Group fell 7% after a recent rally and are now 68% down.

AMRQ:Amaroq, FNX:Fonix and HPOW:H-Power all fell 6%.

GAW:Games Workshop, INVP:Investec and JHD:James Halstead all fell 5%, which is especially surprising for INVP, having just been announced as a FTSE 100 entry.

There was some good news

BTG:BTG Consulting went up 7%, and 5% into profit after announcing an acquisition.

AMP:Ampeak Energy went up 13% for no obvious reason, but are still 67% down.

IES:Invinity Energy are still on a roll and went up another 13% this week. It's now even looking possible I may not make a loss on them, which I never would have thought a few years ago. My recent holding is up by 76% and I deeply regret just matching the value of my old holding, as I could have broken even by now if I'd got more at the cheap price. As it is, I need it to double again from here to break even.

Share of the Week is PBX:Probiotix Health, which seems to have had a delayed reaction to recent contract news and went up 15% this week after a 10% drop last week. Whether it will continue to climb is another question though.

Here's the ISA and shares portfolio after week 45 of year 11.

			Weekly Change
Cash	£109.73		-£3.81
Portfolio cost	£116,490.29		+£0
Portfolio sell value (bid price-commission)	£32,791.37	(-71.9%)	+£285.73
Potential profits	£456.04		-£43.92
Yr 11 Dividends	£86.83		+£0
Yr 11 Interest	£1.57		+£0
Yr 11 Profit from sales	£873.14		+£0
Yr 11 proj avg monthly profit	£84.70	(1.2%)	-£2.30
Total Dividends	£12,574.90		+£0
Total Interest	£10.14		+£0
Total Profit from sales	£18,433.41		+£0
Average monthly cash profit	£232.93	(3.2%)	-£0.44
(Sold stocks profit + Dividends - Fees / Months)

The portfolio value actually increased by £285 thanks to IES:Invinity Energy and PBX:Probiotix Health, although the big drops in HPOW:H-Power and AMRQ:Amaroq meant potential profits dropped by £43.

Still pretty flat.

Hugging the trend line

The SIPP looks like this after week 549 overall and week 29 of year 11.

			Weekly Change
Cash	£1,292.07		+£435.99
Portfolio cost	£159,720.80		+£180.21
Portfolio sell value (bid price - commission)	£89,357.39	(-44.1%)	-£4,031.66
Potential profits	£10,217.64		-£3,297.16
Yr 11 Dividends	£1.407.58		+£197.78
Yr 11 Interest	£12.26		+£0
Yr 11 Profit from sales	£9,397.72		+£180.92
Yr 11 proj avg monthly profit	£1,597.39	(19.4%)	-£0.38
Total Dividends	£19,627.78		+£197.78
Total Interest	£32.96		+£0
Total Profit from sales	£34,064.23		+£180.92
Average monthly cash profit	£410.26	(5.0%)	+£2.15

I added £250 injection for monthly savings and got £71 dividend from FOUR:4imprint, £23 from both JHD:James Halstead and KAIN:Kainos Group, and £79 from SBRE:Sabre Insurance, so cash is up. Big drop in portfolio value though, most of which was potential profits.

I sold my 81 shares in SCT:Softcat for 1824.7013p and made £180.92 (13.9%) profit. Given I've now accepted I have a curse, they rocketed the day after to 1864p which would have given me another £30. I bought 1,272 shares in PAF:Pan African Resources with the proceeds at 114.78p costing £1,472.30. They promptly dropped 7% to 106p.

The combination of small profit and dividends was enough to keep year 11 performance pretty flat, and improved long term performance by £2 a month. I hope to get to the stage where I can maintain 5% on dividends alone and the rest will be bonus selling for profit. That won't happen until I can offload the non-dividend shares.

I'll never get to cross that bloody injection line!

Very grim

The up-tick isn't enough to take us back above the trend line.

A depressing week, but I think we're stuck in a period of intense volatility for a while longer yet.

Week 564 Review - SIPP has a good week but Probiotix and Jubilee Metals take off the shine.

A pretty good week spoiled by drops in JLP:Jubilee Metals and PBX:Probiotix Health. The deficit between cost and value improved by £1,229 to £150,316 and the deficit between injection and value reduced to £58,465. Total portfolio value increased to £126,674.

Worst performer was DXRX:Diaceutics, dropping 14% after what looked like pretty good results. If I had any cash in my ISA I'd be buying more.

PBX:Probiotix Health announced a new strategic alliance which is going to be very positive, and the share price promptly fell 10%. I don't understand what's going on.

PRU:Prudential dropped 5% for no obvious reason. They had their AGM this week but there didn't seem to be anything controversial

SBRE:Sabre Insurance also fell 5% and dropped into the red by 1%.

That was the end of the bad news.

FSG:Foresight Group Holdings, IES:Invinity Energy and INVP:Investec all went up 5%.

EDV:Endeavour Mining, PAGE:Pagegroup, POLR:Polar Capital and TRU:Trufin went up 6%, the latter after announcing a tender offer at a premium to the current share price.

SCT:Softcat went up 7%, and after last week's rally my holding is up by 8%.

GGP:Greatland Resources and OPTI:Optibiotix both went up 9%, the latter after decent final results, but 0.5p is a drop in the ocean to what I need.

ATYM:Atalya Mining had a great week, climbing 11% and taking my holding 2% into profit.

Share of the Week is W7L:Warpaint London, which went up 14% but my holding is still 10% down. This is probably my most volatile share now FXPO:Ferrexpo is suspended.

Here's the ISA and shares portfolio after week 44 of year 11.

			Weekly Change
Cash	£113.54		+£0
Portfolio cost	£116,490.29		+£0
Portfolio sell value (bid price-commission)	£32,505.64	(-72.1%)	-£314.36
Potential profits	£499.96		+£66.48
Yr 11 Dividends	£86.83		+£0
Yr 11 Interest	£1.57		+£0
Yr 11 Profit from sales	£873.14		+£0
Yr 11 proj avg monthly profit	£87.00	(1.2%)	-£2.02
Total Dividends	£12,574.90		+£0
Total Interest	£10.14		+£0
Total Profit from sales	£18,433.41		+£0
Average monthly cash profit	£233.37	(3.2%)	-£0.41
(Sold stocks profit + Dividends - Fees / Months)

The drops was due to the large JLP:Jubilee Metals and PBX:Probiotix Health holdings dropping more than OPTI:Optibiotix went up, as well as the big drop in DXRX:Diaceutics. Potential profits increased due to another positive week for IES:Invinity Energy, and TRU:Trufin climbing 6%.

It's been pretty flat for a while now

Hugging the trend line!

The SIPP looks like this after week 548 overall and week 28 of year 11.

			Weekly Change
Cash	£846.08		+£130.82
Portfolio cost	£159,540.59		+£0
Portfolio sell value (bid price - commission)	£93,208.84	(-41.6%)	+£1,543.99
Potential profits	£13,514.80		+£1,159.78
Yr 11 Dividends	£1.209.80		+£130.82
Yr 11 Interest	£12.26		+£0
Yr 11 Profit from sales	£9,216.80		+£0
Yr 11 proj avg monthly profit	£1,597.77	(19.4%)	-£38.18
Total Dividends	£19,430.00		+£130.82
Total Interest	£32.96		+£0
Total Profit from sales	£33,883.31		+£0
Average monthly cash profit	£408.11	(5.0%)	+£0.29

Cash went up £130 thanks to a £29 dividend from ARBB:Arbuthnot Banking, £20 from BPCR:BioPharma Credit, £9 from ESTC:European Smaller Companies Trust, £24 from FRES:Fresnillo, £19 from GAW:Games Workshop and £26 from UKW:Greencoat UK Wind.

Portfolio value increased by £1,543, most of which was increased profits, and the dividends were enough to slightly improve long term performance.

Still trying to get back to the injection line.

Back on the trend line is progress.

Another 4 dividends coming next week, so performance is at least staying constant without me needing to sell any shares. Only just over 2 months before I re-generate my magic formula ranking, which could see some nice profits realised, although I think I'd rather my holdings remain in the top 50 so I can get more.

Week 563 Review - Gold drags down some great performers.

Not a bad week overall, but spoiled by big drops in gold miners, so the deficit between cost and value widened by £432 to £151,546 and the deficit between injection and value widened to £59,825. Total portfolio value dropped to £125,313.

Biggest drop was GGP:Greatland Resources which fell 9% as all the gold miners had a bad week.

AMP:Ampeak Energy slid 8% for no obvious reason.

EDV:Endeavour Mining dropped 6%. I guess I should be grateful the other miners only lost 3%.

FOUR:4imprint went up 5% and are now only 9% down.

SBRE:Sabre Insurance went up 5% after a positive trading statement.

FDM:FDM Group rose 6% after a positive AGM statement, but are still 67% down.

GAW:Games Workshop also went up 6% following a trading statement, and my holding is now up by 67%.

RSW:Renishaw have been gaining momentum since their trading statement in early May, and climbed another 6% this week to go 24% up.

KNOS:Kainos Group zoomed up 8% following their year-end results. They are still 4% down, but almost back in profit.

W7L:Warpaint London have been a bit volatile since I bought them. They went up 9% this week for no obvious reason, but are still 20% down despite being in profit not long ago.

SCT:Softcat would normally have won Share of the Week following an 18% rise on their Q3 trading statement. They are now 1% in profit and hopefully will stay in the black.

Share of the Week is IES:Invinity Energy, which soared 49% after announcing a deal to build the biggest vanadium redox flow battery in the world. That puts my recent purchase up by 48% but my long-standing purchase is still down 81%. It does however justify my decision to buy a small amount in the retail offer, as I will break even at 75p rather than 161p, which is 100% increase from the current price, and achievable if they get another few contracts like this for grid-scale storage, and they can use this as a demo to help win those contracts.

It was nice to have a week where shares went up or down for genuine reasons, rather than the random nonsense we've had over the last few months.

Here's the ISA and shares portfolio after week 43 of year 11.

			Weekly Change
Cash	£113.54		+£0.17
Portfolio cost	£116,490.29		+£0
Portfolio sell value (bid price-commission)	£32,820.00	(-71.8%)	-£321.30
Potential profits	£433.48		+£16.72
Yr 11 Dividends	£86.83		+£0
Yr 11 Interest	£1.57		+£0.17
Yr 11 Profit from sales	£873.14		+£0
Yr 11 proj avg monthly profit	£89.02	(1.2%)	-£2.10
Total Dividends	£12,574.90		+£0
Total Interest	£10.14		+£0.17
Total Profit from sales	£18,433.41		+£0
Average monthly cash profit	£233.78	(3.2%)	-£0.42
(Sold stocks profit + Dividends - Fees / Months)

JLP:Jubilee Metals dropped, as did most of the other shares, but that was the main thing that wiped out any improvement from IES:Invinity Energy. Potential profits only went up £16 despite IES going £147 into profit, as all my other profitable shares dropped.

Still bad.

Tied to the trend line.

The SIPP looks like this after week 547 overall and week 27 of year 11.

			Weekly Change
Cash	£715.26		+£96.90
Portfolio cost	£159,540.59		+£0
Portfolio sell value (bid price - commission)	£91,664.85	(-42.5%)	-£110.72
Potential profits	£12,355.02		-£262.43
Yr 11 Dividends	£1.078.98		+£34.08
Yr 11 Interest	£12.26		+£0.32
Yr 11 Profit from sales	£9,216.80		+£0
Yr 11 proj avg monthly profit	£1,635.95	(19.9%)	-£57.19
Total Dividends	£19,299.18		+£34.08
Total Interest	£32.96		+£0.17
Total Profit from sales	£33,883.31		+£0
Average monthly cash profit	£407.82	(5.0%)	-£0.47

Cash went up £96 thanks to £62 tax rebate, a £26 dividend from CKN:Clarkson and a £8 dividend from SCT:Softcat.

Portfolio value only fell £110 but potential profits dropped £262 as my gold mines are mostly in profit. 

Just can't get above that pesky injection line!

Still below the trend line. Quite frustrating as it shouldn't take too much to drag it up to flat.

Still no sign of being able to sell anything to get back above the trend line. My main hope is JLP:Jubilee Metals, but it's a forlorn hope at the moment. I will definitely be selling all the ones in my SIPP at some point, but currently that would involve a £7,400 loss. Break-even would be 5.62p from the current 2.8p. My targets were between 8p and 11.5p to get £9,283 profit, but the way things are going at the moment, I'm tempted to sell the lot at 6p and take £1,000 profit, because it would liberate £15k to buy magic formula shares and still leave me with £25k invested in my ISA. The thing with JLP is they do move very quickly when they decide to move, but usually in the wrong direction.

If I can't offload JLP then I'll need to wait until August when I re-generate my magic formula ranking and dispose of anything that falls out of the top 50.

Week 562 Review - Good week for ISA, bad week for SIPP.

This was a pretty bad week for my SIPP, but a pretty good week for my ISA, so the two cancelled each other out and I ended up with the deficit between cost and value reduced by £96 to £151,114. It would have been £2,800 if Friday hadn't spoiled everything. The deficit between injection and value reduced to £59,490 and total portfolio value increased to £125.648.

The biggest faller was TLOU:Tlou Energy which dropped 22% and I fear is almost certainly doomed.

PAGE:Pagegroup went ex-dividend which didn't help, as they dropped another 15% to go 78% down.

III:3i Group gave decent results, but as with last time, the growth in Action stores wasn't enough to stop a sell-off and they went down 14%. At one point they were down 25% so someone got some cheap shares.

PAF:Pan African Resources was the worst hit of the gold miners dropping 8%, but most of them went up more last week than their losses this week so I suspect an element of profit taking.

FNX:Fonix and FRES:Fresnillo dropped 7%.

EDV:Endeavour Mining and FOUR:4imprint dropped 6%.

DXRX:Diaceutics, GGP:Greatland Resources, MSI:MS International and TAM:Tatton Asset Management all dropped 5%.

Not many big risers this week, but fortunately 2 of them are my biggest holdings which is why the ISA did so much better than the SIPP.

JLP:Jubilee Metals climbed 6% for no obvious reason. It may be the price of copper going up, but my other copper shares did less well.

OPTI:Optibiotix announced an event to allow shareholders to taste Sweetbiotix which means we may actually have a product at last. That drove the share price up 10%. Any significant news on this could lead to a re-rate. I hope so as everything else in my micrbiome shares is still looking bleak. The longer it takes SBTX:SkinBioTherapeutics to investigate the possible fraud, the more worried I get about how serious it is.

Share of the Week is IES:Invinity Energy which zoomed up 26% after announcing a massive battery system going live. This should act as a great selling and demo site and will hopefully generate a lot more orders. My recent purchase is only 1% down , but my older holding is still 87% down. I need a 200% rise for the 2 to cancel each other out and break even.

Here's the ISA and shares portfolio after week 42 of year 11.

			Weekly Change
Cash	£113.37		-£3.92
Portfolio cost	£116,490.29		+£0
Portfolio sell value (bid price-commission)	£33,141.30	(-71.6%)	+£1,212.74
Potential profits	£416.76		-£45.49
Yr 11 Dividends	£86.83		+£0
Yr 11 Interest	£1.40		+£0
Yr 11 Profit from sales	£873.14		+£0
Yr 11 proj avg monthly profit	£91.12	(1.3%)	-£2.64
Total Dividends	£12,574.90		+£0
Total Interest	£9.97		+£0
Total Profit from sales	£18,433.41		+£0
Average monthly cash profit	£234.20	(3.2%)	-£0.45
(Sold stocks profit + Dividends - Fees / Months)

Cash dropped due to fees, big increase in value thanks to JLP:Jubilee Metals and OPTI:Optibiotix, but DXRX:Diaceutics dropped back to loss and my potential profits dipped £45.

Well it's the right direction I suppose.

Bang on the trend line.

The SIPP looks like this after week 546 overall and week 26 of year 11.

			Weekly Change
Cash	£618.36		-£398.35
Portfolio cost	£159,540.59		+£497.26
Portfolio sell value (bid price - commission)	£91,775.57	(-42.5%)	-£1,116.03
Potential profits	£12,617.45		-£1,265.50
Yr 11 Dividends	£1.044.90		+£102.94
Yr 11 Interest	£11.94		+£0
Yr 11 Profit from sales	£9,216.80		+£0
Yr 11 proj avg monthly profit	£1,693.14	(20.6%)	-£50.58
Total Dividends	£19,265.10		+£102.94
Total Interest	£32.64		+£0
Total Profit from sales	£33,883.31		+£0
Average monthly cash profit	£408.29	(5.0%)	+£0.03

It was monthly investment time. I bought 107 shares in ESTC:European Smaller Companies Trust at 231.9565p costing £249.43 and 37 shares in BPM:BP Marsh & Partners at 669.8p costing £247.83. I'll buy both of these again next month.

Lots of dividends this week totaling £102. £15 from PRU:Prudential, £43.52 from RAT:Rathbones, £13 from SOI:Schroder Oriental Income and £36 from THX:Thor Explorations.

Value was smashed mainly from the miners, and potential profit went down more than the value as the biggest increases were in loss-making shares.

There's just something stopping me getting past that injection line! Whenever I get close there's some national or global crisis that spoils everything. They say you have to be patient to do this, and they seem to be right.

Below the trend line is bad.

Although we're below the trend line now, I think it will stay pointing up for quite a while unless I suffer some massive loss, which could easily happen.